NeoStrata Company, Inc. Report issue

For profit Phase 3
Founded: Princeton NJ United States (1988)
Status: Acquired by Johnson and Johnson (2015)

Organization Overview

First Clinical Trial
2007
NCT00705900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6